@2105 I'm thinking more of a serious rerate this side of Xmas!
Disruptive as this tech may be, if the evaluation from a ‘suitable’ commercial foundry is found to be positive then the next step could be a publicly announced 'appraisal' from at least one of them that this tech is worthy of pursuing further as it works to improve subsequent generations and fine tune the device designs.
An appraisal might just be the kind of validation that Archer requires for its SH to be taken in a more meaningful light.
AIMO DYOR GLTA(patient)H
Ann: MPW validation of first-generation Biochip gFET chip design, page-5
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.010(2.56%) |
Mkt cap ! $96.84M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 37.0¢ | $231.3K | 600.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19905 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44600 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AXE (ASX) Chart |